Singapore markets closed

ResMed Inc. (RMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
224.41-5.44 (-2.37%)
As of 09:48AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 33.94B
Enterprise value 34.58B
Trailing P/E 43.73
Forward P/E 35.59
PEG Ratio (5 yr expected) 3.15
Price/sales (ttm)9.52
Price/book (mrq)10.10
Enterprise value/revenue 9.66
Enterprise value/EBITDA 28.96

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 3-9.47%
S&P500 52-week change 3-14.73%
52-week high 3275.66
52-week low 3189.40
50-day moving average 3228.93
200-day moving average 3228.81

Share statistics

Avg vol (3-month) 3468.71k
Avg vol (10-day) 3435.45k
Shares outstanding 5146.46M
Implied shares outstanding 6N/A
Float 8145.05M
% held by insiders 11.35%
% held by institutions 167.37%
Shares short (14 Sept 2022) 41.51M
Short ratio (14 Sept 2022) 43.45
Short % of float (14 Sept 2022) 41.16%
Short % of shares outstanding (14 Sept 2022) 41.03%
Shares short (prior month 14 Aug 2022) 41.32M

Dividends & splits

Forward annual dividend rate 41.76
Forward annual dividend yield 40.77%
Trailing annual dividend rate 31.68
Trailing annual dividend yield 30.73%
5-year average dividend yield 41.02
Payout ratio 431.70%
Dividend date 321 Sept 2022
Ex-dividend date 416 Aug 2022
Last split factor 22:1
Last split date 330 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2022
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 21.78%
Operating margin (ttm)27.96%

Management effectiveness

Return on assets (ttm)12.73%
Return on equity (ttm)24.96%

Income statement

Revenue (ttm)3.58B
Revenue per share (ttm)24.50
Quarterly revenue growth (yoy)4.40%
Gross profit (ttm)2.06B
EBITDA 1.12B
Net income avi to common (ttm)779.44M
Diluted EPS (ttm)5.30
Quarterly earnings growth (yoy)-0.00%

Balance sheet

Total cash (mrq)273.71M
Total cash per share (mrq)1.87
Total debt (mrq)917.55M
Total debt/equity (mrq)27.30
Current ratio (mrq)2.80
Book value per share (mrq)22.95

Cash flow statement

Operating cash flow (ttm)351.15M
Levered free cash flow (ttm)117.35M